Support for the DOPPS Program

The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program is funded by a consortium of private industry, public funders, and professional societies, with the shared mission of providing a strong scientific basis for the identification of dialysis and CKD practices that are most associated with improved patient survival and quality of life. Since starting in 1996, the base of funding has expanded to include grants from over 15 funders to support different facets of the collection, analysis, and dissemination of this important information.

Arbor Research Collaborative for Health recognizes supporters for their generous contributions to the DOPPS Program. Such support enables us to continue our mission to identify best practices for improving patient care, and disseminate this important information to the medical community and others in the renal industry. Arbor Research and our DOPPS collaborators gratefully acknowledge the generous support from sponsors, and their strong commitment to independent scientific research for improved patient care.

  • Amgen Inc (since 1996, founding sponsor)
  • Akebia Therapeutics, Inc.
  • Astellas Pharma Inc.
  • Bard Peripheral Vascular, Inc.
  • Baxter Healthcare Corp
  • Bayer AG & Bayer Yakuhin, Ltd.
  • Cara Therapeutics, Inc.
  • Chugai Pharmaceutical Co., Ltd.
  • CSL-Vifor, Ltd.
  • GlaxoSmithKline LLC
  • Horizon Therapeutics, PLC
  • Japanese Society for Peritoneal Dialysis (JSPD)
  • JMS Co., Ltd.
  • Kidney Foundation Japan (KFJ)
  • Kissei Pharmaceutical Co., Ltd.
  • Kyowa Kirin Co., Ltd. (since 1999 for Japan DOPPS)
  • Merck Sharp & Dohme Corp
  • Nikkiso Co., Ltd.
  • ONO Pharmaceutical Co., Ltd.
  • Outset Medical, Inc.
  • Terumo Corporation
  • Torii Pharmaceutical Co., Ltd.

Public funding and support has been provided for specific DOPPS projects, ancillary studies, or affiliated research projects by: 
  • France: French National Institute of Health and Medical Research (INSERM)
  • Thailand: Thailand Research Foundation (TRF); Chulalongkorn University Matching Fund; King Chulalongkorn Memorial Hospital Matching Fund; National Research Council of Thailand (NRCT) 
  • United Kingdom: National Institute for Health Research (NIHR) via the Comprehensive Clinical Research Network (CCRN)
  • United States: Agency for Healthcare Research and Quality (AHRQ); National Institutes of Health (NIH)

All support is provided without restrictions on publications.

Last updated 4/21/2023